当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第15期
编号:13382441
原发性乳腺神经内分泌癌的研究进展(5)
http://www.100md.com 2019年4月16日 《医学信息》 2019年第15期
     [32]Berruti A,Saini A,Leonardo E,et al.Management of neuroendocrine differentiated breast carcinoma[J].Breast,2004,13(6):527-529.

    [33]Latif N,Rosa M,Samian L,et al.An unusual case of primary small cell neuroendocrine carcinoma of the breast[J].Breast J,2010,16(6):647-651.

    [34]Brask J B,Talman M L M,Wielenga V T.Neuroendocrine carcinoma of the breast - a pilot study of a Danish population of 240 breast cancer patients[J].APMIS,2014,122(7):585-592.

    [35]Makretsov N,Gilks CB,Coldman AJ,et al.Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer[J].Hum Patho,2003,34(10): 1001-1008.

    [36]Miremadi A,Pinder SE,Lee AH,et al.Neuroendocrine differentiation and prognosis in breast adenocarcinoma[J].Histopathology,2002,40(3):215-222.

    [37]van Krimpen C,Elferink A,Broodman CA,et al.The prognostic influence of neuroendocrine differentiationin breast cancer:results of a long-term follow-up study[J].Breast,2004.13(4): 329-333.

    收稿日期:2019-5-13;修回日期:2019-5-25

    編辑/肖婷婷, http://www.100md.com(曹技磊 王钢乐)
上一页1 2 3 4 5